Insider Buying: Merit Medical Systems (NASDAQ:MMSI) Insider Purchases $125,240.00 in Stock

Merit Medical Systems, Inc. (NASDAQ:MMSI) insider Brian Lloyd bought 2,000 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The shares were purchased at an average price of $62.62 per share, for a total transaction of $125,240.00. Following the completion of the purchase, the insider directly owned 2,000 shares of the company’s stock, valued at approximately $125,240. This trade represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.

Merit Medical Systems Stock Performance

Shares of MMSI opened at $62.62 on Thursday. The stock has a 50 day moving average price of $68.13 and a 200 day moving average price of $78.73. The company has a quick ratio of 3.46, a current ratio of 5.08 and a debt-to-equity ratio of 0.45. The company has a market capitalization of $3.74 billion, a price-to-earnings ratio of 27.11, a price-to-earnings-growth ratio of 1.90 and a beta of 0.58. Merit Medical Systems, Inc. has a 52-week low of $59.74 and a 52-week high of $100.05.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings results on Thursday, April 30th. The medical instruments supplier reported $0.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.84 by $0.10. The firm had revenue of $381.88 million during the quarter, compared to the consensus estimate of $377.59 million. Merit Medical Systems had a return on equity of 13.54% and a net margin of 9.03%.The firm’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same period in the prior year, the company posted $0.86 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. Research analysts predict that Merit Medical Systems, Inc. will post 3.61 EPS for the current fiscal year.

Institutional Trading of Merit Medical Systems

Large investors have recently made changes to their positions in the stock. Los Angeles Capital Management LLC acquired a new stake in shares of Merit Medical Systems during the fourth quarter valued at $25,000. Maseco LLP acquired a new stake in shares of Merit Medical Systems during the fourth quarter valued at $26,000. Torren Management LLC acquired a new stake in Merit Medical Systems in the 4th quarter worth about $38,000. Covestor Ltd boosted its stake in Merit Medical Systems by 252.6% in the 4th quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier’s stock worth $41,000 after buying an additional 336 shares during the last quarter. Finally, Danske Bank A S acquired a new stake in Merit Medical Systems in the 3rd quarter worth about $42,000. Institutional investors and hedge funds own 99.66% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently commented on MMSI. JPMorgan Chase & Co. cut their price target on Merit Medical Systems from $95.00 to $77.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Compass Point set a $107.00 price target on Merit Medical Systems in a research note on Monday, April 20th. Barrington Research cut their price target on Merit Medical Systems from $109.00 to $107.00 and set an “outperform” rating for the company in a research note on Monday, April 20th. Weiss Ratings cut Merit Medical Systems from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, May 8th. Finally, Needham & Company LLC cut their price objective on Merit Medical Systems from $101.00 to $90.00 and set a “buy” rating for the company in a research report on Friday, May 1st. Eight analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $92.80.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.